Burning Rock Biotech Limited reiterated revenue guidance for the full year 2023. For the period, the company expects revenue guidance of approximately 20% growth over 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.793 USD | +1.73% | -1.73% | -14.73% |
Apr. 02 | Earnings Flash (BNR.L) BURNING ROCK BIOTECH Posts FY23 Revenue $75.7M | MT |
Apr. 02 | Earnings Flash (BNR.L) BURNING ROCK BIOTECH Posts FY23 Loss $-0.90 | MT |
- Stock Market
- Equities
- BNR Stock
- News BURG ROCK
- Burning Rock Biotech Limited Reiterates Revenue Guidance for the Full Year 2023